Supplementary Table 1 from Phase I/II Trial of Orteronel (Tak-700)—An Investigational 17,20-Lyase Inhibitor—in Patients with Metastatic Castration-Resistant Prostate Cancer

Robert Dreicer,David MacLean,Ajit Suri,Walter M. Stadler,Daniel Shevrin, Lowell Hart, Gary R. MacVicar,Omid Hamid,John Hainsworth, Mitchell E. Gross, Yuanjun Shi, Iain J. Webb, David B. Agus

openalex（2023）

Cited 0|Views0

Key words

Metastatic Prostate Cancer,Prostate Cancer

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined